Literature DB >> 15140709

Frequency of asymptomatic microbleeds on T2*-weighted MR images of patients with recurrent stroke: association with combination of stroke subtypes and leukoaraiosis.

Hiromitsu Naka1, Eiichi Nomura, Shinichi Wakabayashi, Hiroshi Kajikawa, Tatsuo Kohriyama, Yasuyo Mimori, Shigenobu Nakamura, Masayasu Matsumoto.   

Abstract

BACKGROUND AND
PURPOSE: Asymptomatic microbleeds shown by T2*-weighted MR imaging are associated with small-artery diseases, especially with intracerebral hemorrhage. Few studies have focused on the prevalence of microbleeds in patients with recurrent stroke. We investigated frequency of microbleeds in patients with recurrent stroke and association of presence of microbleeds with a combination of stroke subtypes and severity of leukoaraiosis.
METHODS: The study population consisted of 102 patients with primary stroke and 54 patients with recurrent stroke. Microbleeds were counted and classified by using T2*-weighted MR imaging with a 1.0-T system.
RESULTS: Patients with recurrent stroke showed a significantly higher prevalence of microbleeds (68.5%) than did patients with primary stroke (28.4%) (P <.0001). Among patients with recurrent stroke, the highest frequency of microbleeds occurred in those with intracerebral hemorrhage alone (92.3%), with the next highest frequency occurring in those with a combination of intracerebral hemorrhage and ischemic stroke (76.5%) and then those with ischemic stroke alone (50.0%) (P <.05). Leukoaraiosis was more severe in patients with recurrent stroke than in patients with primary stroke, and correlations between grade of microbleeds and severity of leukoaraiosis were found in patients with primary stroke (r = 0.367, P <.001) and in patients with recurrent stroke (r = 0.553, P <.0001). Logistic regression analysis identified recurrent stroke (odds ratio, 4.487; 95% confidence interval, 1.989-10.120) and leukoaraiosis (odds ratio, 5.079; 95% confidence interval, 2.125-12.143) as being significantly and independently associated with microbleeds.
CONCLUSION: Asymptomatic microbleeds are observed to occur frequently in patients with recurrent stroke, either hemorrhagic or ischemic stroke, and are closely associated with the severity of leukoaraiosis.

Entities:  

Mesh:

Year:  2004        PMID: 15140709      PMCID: PMC7974475     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  27 in total

1.  Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions.

Authors:  Seung-Hoon Lee; Hee-Joon Bae; Byung-Woo Yoon; Ho Kim; Dong-Eog Kim; Jae-Kyu Roh
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

2.  MRI of acute post-ischemic cerebral hemorrhage in stroke patients: diagnosis with T2*-weighted gradient-echo sequences.

Authors:  M Hermier; N Nighoghossian; L Derex; Y Berthezène; K Blanc-Lasserre; P Trouillas; J C Froment
Journal:  Neuroradiology       Date:  2001-10       Impact factor: 2.804

3.  MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy.

Authors:  S M Greenberg; H C O'Donnell; P W Schaefer; E Kraft
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

4.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

5.  Multifocal low-signal brain lesions on T2*-weighted gradient-echo imaging.

Authors:  Y Tsushima; T Tamura; Y Unno; S Kusano; K Endo
Journal:  Neuroradiology       Date:  2000-07       Impact factor: 2.804

6.  Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application.

Authors:  Chelsea S Kidwell; Jeffrey L Saver; J Pablo Villablanca; Gary Duckwiler; Andre Fredieu; Kristi Gough; Megan C Leary; Sidney Starkman; Y Pierre Gobin; Reza Jahan; Paul Vespa; David S Liebeskind; Jeffry R Alger; Fernando Vinuela
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

7.  Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds.

Authors:  F Fazekas; R Kleinert; G Roob; G Kleinert; P Kapeller; R Schmidt; H P Hartung
Journal:  AJNR Am J Neuroradiol       Date:  1999-04       Impact factor: 3.825

8.  Leukoaraiosis and intracerebral hematoma.

Authors:  K Selekler; C Erzen
Journal:  Stroke       Date:  1989-08       Impact factor: 7.914

9.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

10.  A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group.

Authors:  W K Hass; J D Easton; H P Adams; W Pryse-Phillips; B A Molony; S Anderson; B Kamm
Journal:  N Engl J Med       Date:  1989-08-24       Impact factor: 91.245

View more
  29 in total

Review 1.  Subclinical Cerebrovascular Disease: Epidemiology and Treatment.

Authors:  Adam de Havenon; Chelsea Meyer; J Scott McNally; Matthew Alexander; Lee Chung
Journal:  Curr Atheroscler Rep       Date:  2019-07-27       Impact factor: 5.113

2.  Positional relationship between recurrent intracerebral hemorrhage/lacunar infarction and previously detected microbleeds.

Authors:  Y Sueda; H Naka; T Ohtsuki; T Kono; S Aoki; T Ohshita; E Nomura; S Wakabayashi; T Kohriyama; M Matsumoto
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-06       Impact factor: 3.825

3.  Association between carotid artery plaque type and cerebral microbleeds.

Authors:  L Saba; R Montisci; E Raz; R Sanfilippo; J S Suri; M Piga
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-24       Impact factor: 3.825

4.  Traumatic microbleeds suggest vascular injury and predict disability in traumatic brain injury.

Authors:  Allison D Griffin; L Christine Turtzo; Gunjan Y Parikh; Alexander Tolpygo; Zachary Lodato; Anita D Moses; Govind Nair; Daniel P Perl; Nancy A Edwards; Bernard J Dardzinski; Regina C Armstrong; Abhik Ray-Chaudhury; Partha P Mitra; Lawrence L Latour
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

5.  Imaging and clinical characteristics of children with multiple foci of microsusceptibility changes in the brain on susceptibility-weighted MRI.

Authors:  Tetsu Niwa; Noriko Aida; Taro Takahara; Thomas C Kwee; Kazutoshi Fujita; Ayako Shishikura; Daiki Miyata; Tomio Inoue
Journal:  Pediatr Radiol       Date:  2010-04-28

6.  Underlying embolic and pathologic differentiation by cerebral microbleeds in cryptogenic stroke.

Authors:  Muneaki Kikuno; Yuji Ueno; Takahiro Shimizu; Ayako Kuriki; Yohei Tateishi; Ryosuke Doijiri; Yoshiaki Shimada; Hidehiro Takekawa; Eriko Yamaguchi; Masatoshi Koga; Yuki Kamiya; Masafumi Ihara; Akira Tsujino; Koichi Hirata; Kazunori Toyoda; Yasuhiro Hasegawa; Hitoshi Aizawa; Nobutaka Hattori; Takao Urabe
Journal:  J Neurol       Date:  2020-02-03       Impact factor: 4.849

7.  Silent microbleeds and old hematomas in spontaneous cerebral hemorrhages.

Authors:  Jae-Bum Lim; Ealmaan Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-07-31

8.  Comparison of ESWAN, SWI-SPGR, and 2D T2*-weighted GRE sequence for depicting cerebral microbleeds.

Authors:  L F Guo; G Wang; X Y Zhu; C Liu; L Cui
Journal:  Clin Neuroradiol       Date:  2012-12-03       Impact factor: 3.649

9.  Management of Primary Hypertensive Hemorrhage of the Brain.

Authors:  James C Grotta
Journal:  Curr Treat Options Neurol       Date:  2004-11       Impact factor: 3.598

10.  Association between cerebral microbleeds on T2*-weighted MR images and recurrent hemorrhagic stroke in patients treated with warfarin following ischemic stroke.

Authors:  H Ueno; H Naka; T Ohshita; K Kondo; E Nomura; T Ohtsuki; T Kohriyama; S Wakabayashi; M Matsumoto
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-22       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.